Immunohistochemical expression of p16ink4a in patients with squamous cell carcinoma of the cervix- a one year prospective and retrospective study in a tertiary care hospital

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/279

Full metadata record

DC Field	Value	Language
dc.contributor.author	Dr.Pravallika K, BN0118003	-
dc.date.accessioned	2021-03-18T12:53:11Z	-
dc.date.available	2021-03-18T12:53:11Z	-
dc.date.issued	2021	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/279	-
dc.description.abstract	BACKGROUND: Worldwide, carcinoma of uterine cervix is the fourth common cancer in women and becomes the prevalent cause of mortality in women. The P16ink4a is a tumour suppressor protein located on chromosome 9p21. It acts by preventing the progression of cell cycle from G1 to S phase. Its overexpression is demonstrated by immunohistochemical staining and it is known to have an effect on treatment response and survival of patients. It is not known to show positivity in normal cervical epithelium. This research was undertaken to study the expression of P16ink4a in cervical squamous cell carcinoma cases. Its role as a possible marker by correlating its positive expression with clinicopathological parameters was also studied.	en_US
dc.language.iso	en	en_US
dc.publisher	K.L.E. Academy of Higher Education & Research, Belagavi	en_US
dc.subject	Squamous cell carcinoma cervix, Keratinizing, Non-keratinizing, P16ink4a, IHC, clinic-pathological parameters	en_US
dc.title	Immunohistochemical expression of p16ink4a in patients with squamous cell carcinoma of the cervix- a one year prospective and retrospective study in a tertiary care hospital	en_US
dc.type	Dissertations	en_US
Appears in Collections:	Pathology

Files in This Item:

File	Description	Size	Format
BN0118003 Dr.Pravallika K.pdf		3.25 MB	Adobe PDF	View/Open